Feedback / Questions
PALI-2108 - Palisade Bio
https://www.globenewswire.com/news-release/2025/05/27/3088623/0/en/Palisade-Bio-Reports-Positive-Phase-1a-Results-for-PALI-2108-a-First-in-Class-Terminal-Ileum-and-Colon-Targeted-PDE4-B-D-Inhibitor-for-Fibrostenotic-Crohn-s-Disease-and-Ulcerative-.html
May 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next